Tefron, which has undergone significant restructuring since the end of 2009 posted a net loss of US$2.0 million, compared to a loss of US$4.6 million in the same quarter last year. Revenues were US$24.94 million compared with US$25.26 million in the year-ago period while operating loss for the latest quarter also narrowed to US$2.3 million from US$5.7 million.